Johnson & Johnson: Precision Medicine in Immune-Mediated Disease

Aim: Innovators with transformative potential solutions to help or aim to advance precision medicine approaches in immune-mediated diseases are invited to apply. This may include:

• Novel approaches toward patient stratification and precision medicine that can be harnessed in immune-mediated diseases including:
  • Multidimensional biomarker discovery platforms, including those with AI/ML based analytics
  • Deep patient clinical and molecular phenotyping data sets
  • Novel biomarkers for patient segmentation including digital and imaging biomarkers
• Novel therapies with clear precision medicine strategy to address a defined patient segment
• Enabling technologies for clinical trials:
  • Potential solutions aiming to identify and recruit specific patient sub-populations
  • Potential solutions aiming to resolve technical issues associated with large scale PBMC collection and preparation for multiomics analysis
  • High dimensional blood immune profiling platforms (e.g., cellular, autoantibodies, complement, proteomics, exosomes, mass spec)
  • Tissue based single cell RNA sequencing

Funding: up to a total of $500,000

https://jlabs.jnjinnovation.com/quickfire-challenges/immunology-innovations-quickfire-challenge-precision-medicine-in-immune-mediated-disease